Fully enrolled two Phase 2 studies with data from both expected in the second half of 2024First patient dosed in new Phase 2 breast cancer prevention studyData from ongoing Phase
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
SEATTLE, Jan. 09, 2024 Atossa Therapeutics, Inc. , a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus.
Atossa Therapeutics (ATOS) Approved in Canada to Conduct Phase 2 EVANGELINE Trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.